Doctor profile · Federal record
Dr. Roland Chan, M.D.
Rheumatology Physician (CMS: Internal Medicine) · Internal Medicine Physician · N Dartmouth, MA
- NPI 1912986100
- 33 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
535 Faunce Corner Road
N Dartmouth, MA 027473717
(508) 996-3991 - Mailing address
-
535 Faunce Corner RD
N Dartmouth, MA 027471242
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- April 24, 2023
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Massachusetts #153087
- Medicaid
- MA #3183165
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1912986100. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
13,925
Distinct HCPCS
10
Medicare allowed
$404,692
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 4,500 | 49 | $23 | |
Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 3,420 | 16 | $19 | |
36415 |
Insertion of needle into vein for collection of blood sample | 853 | 386 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 792 | 436 | $128 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 490 | 211 | $8 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 344 | 30 | $1 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 342 | 255 | $91 | |
80048 |
Blood test, basic group of blood chemicals (calcium, total) | 255 | 176 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 200 | 89 | $10 | |
J3489 |
Injection, zoledronic acid, 1 mg | 194 | 39 | $9 |
In context: peer comparison
Among 1 peers in N Dartmouth Rheumatology Physician, average services per provider: 302. This provider delivers 46× the peer median.Open Payments
Industry payments received
All-time total
$1,816
Transactions
85
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 39 | $748.14 | |
| Amgen INC. | 22 | $433.92 | |
| Genzyme Corporation | 5 | $152.79 | |
| Janssen Biotech, INC. | 3 | $97.83 | |
| AstraZeneca Pharmaceuticals Lp | 5 | $91.88 | |
| Ucb, INC. | 2 | $65.03 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $57.16 | |
| Fresenius Kabi USA, LLC | 2 | $51.63 | |
| GlaxoSmithKline, LLC. | 2 | $41.81 | |
| Sobi, INC | 1 | $28.77 | |
| Scilex Pharmaceuticals INC. | 1 | $24.85 | |
| Sandoz INC. | 1 | $22.17 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,074
Patients
964
Total drug cost
$949,796
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 770 | 187 | $10,627 |
| Gabapentin | Generic | 441 | 82 | $6,693 |
| Methotrexate (Methotrexate Sodium) | Brand | 384 | 93 | $15,562 |
| Hydroxychloroquine Sulfate | Generic | 380 | 92 | $18,533 |
| Meloxicam | Generic | 372 | 102 | $2,122 |
| Allopurinol | Generic | 287 | 80 | $4,789 |
| Celecoxib | Generic | 230 | 49 | $12,626 |
| Duloxetine Hcl | Generic | 211 | 45 | $4,720 |
| Diclofenac Sodium | Generic | 191 | 46 | $3,164 |
| Alendronate Sodium | Generic | 184 | 58 | $2,913 |
Hospital affiliations
Frequently asked questions
What is Dr. Roland Chan's medical specialty?
Dr. Roland Chan practices Rheumatology Physician in N Dartmouth, MA.
Where does Dr. Roland Chan practice?
Dr. Roland Chan practices at 535 Faunce Corner Road, N Dartmouth, MA 027473717. Office phone: 5089963991.
What is Dr. Roland Chan's NPI?
Dr. Roland Chan's National Provider Identifier (NPI) is 1912986100, issued by NPPES.
Does Dr. Roland Chan accept Medicare assignment?
Dr. Roland Chan does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Roland Chan commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg (HCPCS Q5103); Insertion of needle into vein for collection of blood sample (HCPCS 36415). Source: CMS Medicare Physician & Other Practitioners file.